Real-World Use of Novel P2Y12 Inhibitors in Patients with Acute Myocardial Infarction: A Treatment Paradox

Publisher： Karger

E-ISSN： 1421-9751|136|1|21-28

ISSN： 0008-6312

Source： Cardiology, Vol.136, Iss.1, 2016-08, pp. : 21-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk of acute myocardial infarction with real‐world NSAIDs depends on dose and timing of exposure

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 1, 2018-01 ,pp. : 69-77

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cytochrome P450 2C19 Polymorphism, Suboptimal Reperfusion and All-Cause Mortality in Patients with Acute Myocardial Infarction

By  

Cardiology, Vol. 117, Iss. 2, 2010-10 ,pp. : 81-87

Karger

Access to resources Recommend Favorite

Differences in the Treatment of Patients with Acute Myocardial Infarction According to Patient Age

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 42, Iss. 8, 1994-08 ,pp. : 826-832

John Wiley & Sons Inc

Access to resources Recommend Favorite

Delayed Thrombolytic Treatment of Older Patients with Acute Myocardial Infarction

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 47, Iss. 10, 1999-10 ,pp. : 1222-1228

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acute myocardial infarction in patients with syncope

By  

Canadian Journal of Emergency Medicine, Vol. 11, Iss. 2, 2009-03 ,pp. : 156-160

Cambridge University Press

Access to resources Recommend Favorite